Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review

Abstract

Psoriasis is a chronic autoimmune inflammatory disease that remains active for a long period, even for life in most patients. The impact of psoriasis on health is not only limited to the skin, but also influences multiple systems of the body, even mental health. With the increasing of literature on the association between psoriasis and extracutaneous systems, a better understanding of psoriasis as an autoimmune disease with systemic inflammation is created. Except for cardiometabolic diseases, gastrointestinal diseases, chronic kidney diseases, malignancy, and infections that have received much attention, the association between psoriasis and more systemic diseases, including the skin system, reproductive system, and oral and ocular systems has also been revealed, and mental health diseases draw more attention not just because of the negative mental and mood influence caused by skin lesions, but a common immune-inflammatory mechanism identified of the two systemic diseases. This review summarizes the epidemiological evidence supporting the association between psoriasis and important and/or newly reported systemic diseases in the past 5 years, and may help to comprehensively recognize the comorbidity burden related to psoriasis, further to improve the management of people with psoriasis.

References 220

1. 1.

   Arnold KA Treister AD Lio PA Alenghat FJ. Association of Atherosclerosis Prevalence With Age, Race, and Traditional Risk Factors in Patients With Psoriasis. JAMA Dermatol (2019 ) 155(5):622–3

   Not in our library10.1001/jamadermatol.2018.5462

2. 2.

   Jung KJ Kim TG Lee JW Lee M Oh J Lee SE. Increased Risk of Atherosclerotic Cardiovascular Disease Among Patients With Psoriasis in Korea: A 15-Year Nationwide Population-Based Cohort Study. J Dermatol (2019 ) 46(10):859–66

   Not in our library10.1111/1346-8138.15052

3. 3.
   Guidelines for the Diagnosis and Treatment of Psoriasis in China: 2019 Concise Edition# · 2020

   Not checked
4. 4.

   Kawazoe S Tokuyama N Mizukami H Ohashi H. Zur Lehre Von Der Neurogenen Und Der Thyreogenen Glykosurie (Schluss Aus No. 18.). Dtsch Med Wochenschr (1897 ) 23(20):309–12.

   Not in our library

5. 5.

   Takeshita J Grewal S Langan SM Mehta NN Ogdie A Van Voorhees AS. Psoriasis and Comorbid Diseases: Epidemiology. J Am Acad Dermatol (2017 ) 76(3):377–90

   Not in our library10.1016/j.jaad.2016.07.064

6. 6.

   Shiba M Kato T Izumi T Miyamoto S Nakane E Haruna T. Risk of Myocardial Infarction in Patients With Psoriasis: A Cross-Sectional Patient-Population Study in a Japanese Hospital. J Cardiol (2019 ) 73(4):276–9

   Not in our library10.1016/j.jjcc.2018.10.008

7. 7.

   Raaby L Ahlehoff O de Thurah A. Psoriasis and Cardiovascular Events: Updating the Evidence. Arch Dermatol Res (2017 ) 309(3):225–8

   Not in our library10.1007/s00403-016-1712-1

8. 8.

   Zhao J Zhang X Sun H An R. Is Psoriasis a Risk Factor of Angiography-Proven Coronary Artery Disease? Br J Dermatol (2018 ) 179(5):1218–9

   Not in our library10.1111/bjd.16925

9. 9.

   Kaiser H Abdulla J Henningsen KMA Skov L Hansen PR. Coronary Artery Disease Assessed by Computed Tomography in Patients With Psoriasis: A Systematic Review and Meta-Analysis. Dermatology (2019 ) 235(6):478–87

   Not in our library10.1159/000502138

10. 10.

    Upala S Shahnawaz A Sanguankeo A. Psoriasis Increases Risk of New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis of Prospective Observational Studies. J Dermatolog Treat Q2 (2017 ) 28(5):406–10

    Not in our library10.1080/09546634.2016.1255703

11. 11.

    Yu X Feng X Xia L Cao S Wei X. Risk of Aortic Aneurysm in Patients With Psoriasis: A Systematic Review and Meta-Analysis of Cohort Studies. Clin Cardiol (2020 ) 43(11):1266–72

    Not in our library10.1002/clc.23438

12. 12.

    Phan K Lee G Fischer G. Pediatric Psoriasis and Association With Cardiovascular and Metabolic Comorbidities: Systematic Review and Meta-Analysis. Pediatr Dermatol Q3-4 (2020 ) 37(4):661–9

    Not in our library10.1111/pde.14208

13. 13.

    Badaoui A Tounian P Mahé E. Psoriasis and Metabolic and Cardiovascular Comorbidities in Children: A Systematic Review. Arch Pediatr Q4 (2019 ) 26(2):86–94

    Not in our library10.1016/j.arcped.2018.12.005

14. 14.

    Keller K Hobohm L Ostad MA Karbach S Espinola-Klein C Münzel T. Psoriasis and Its Impact on the Clinical Outcome of Patients With Pulmonary Embolism. Int J Cardiol (2021 ) 343:114–21

    Not in our library10.1016/j.ijcard.2021.08.042

15. 15.

    Damian AC Colaco K Rohekar S Boyd T Chandran V Gladman DD. The Incidence and Risk Factors for Venous Thromboembolic Events in Patients With Psoriasis and Psoriatic Arthritis. Semin Arthritis Rheum Q1 (2021 ) 51(3):547–52

    Not in our library10.1016/j.semarthrit.2021.04.008

16. 16.

    Laskowski M Schiöler L Gustafsson H Wennberg AM Åberg M Torén K. Cardiorespiratory Fitness in Late Adolescence and Long-Term Risk of Psoriasis and Psoriatic Arthritis Among Swedish Men. PloS One (2021 ) 16(1):e0243348

    Not in our library10.1371/journal.pone.0243348

17. 17.

    Paiva-Lopes MJ Batuca JR Gouveia S Alves M Papoila AL Alves JD. Antibodies Towards High-Density Lipoprotein Components in Patients With Psoriasis. Arch Dermatol Res (2020 ) 312(2):93–102

    Not in our library10.1007/s00403-019-01986-x

18. 18.

    Piaserico S Osto E Famoso G Montisci R De Michieli L Zanetti I. Long-Term Prognostic Value of Coronary Flow Reserve in Psoriasis Patients. Atherosclerosis (2019 ) 289:57–63

    Not in our library10.1016/j.atherosclerosis.2019.08.009

19. 19.

    Kvist-Hansen A Kaiser H Wang X Krakauer M Gørtz PM McCauley BD. Neutrophil Pathways of Inflammation Characterize the Blood Transcriptomic Signature of Patients With Psoriasis and Cardiovascular Disease. Int J Mol Sci (2021 ) 22(19):10818

    Not in our library10.3390/ijms221910818

20. 20.

    Sobchak C Akhtari S Harvey P Gladman D Chandran V Cook R. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease. Arthritis Rheumatol Q1 (2019 ) 71(10):1651–9

    Not in our library10.1002/art.40925

21. 21.

    Sajja A Abdelrahman KM Reddy AS Dey AK Uceda DE Lateef SS. Chronic Inflammation in Psoriasis Promotes Visceral Adiposity Associated With Noncalcified Coronary Burden Over Time. JCI Insight (2020 ) 5(22):e142534

    Not in our library10.1172/jci.insight.142534

22. 22.
    Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis · 2020

    Not checked
23. 23.

    Munger E Choi H Dey AK Elnabawi YA Groenendyk JW Rodante J. Application of Machine Learning to Determine Top Predictors of Noncalcified Coronary Burden in Psoriasis: An Observational Cohort Study. J Am Acad Dermatol (2020 ) 83(6):1647–53

    Not in our library10.1016/j.jaad.2019.10.060

24. 24.

    Garshick MS Barrett TJ Wechter T Azarchi S Scher JU Neimann A. Inflammasome Signaling and Impaired Vascular Health in Psoriasis. Arterioscler Thromb Vasc Biol (2019 ) 39(4):787–98

    Not in our library10.1161/atvbaha.118.312246

25. 25.

    Tsai TY Yen H Huang YC. Serum Homocysteine, Folate and Vitamin B(12) Levels in Patients With Psoriasis: A Systematic Review and Meta-Analysis. Br J Dermatol (2019 ) 180(2):382–9

    Not in our library10.1111/bjd.17034

26. 26.

    Mahil SK McSweeney SM Kloczko E McGowan B Barker JN Smith CH. Does Weight Loss Reduce the Severity and Incidence of Psoriasis or Psoriatic Arthritis? A Critically Appraised Topic. Br J Dermatol (2019 ) 181(5):946–53

    Not in our library10.1111/bjd.17741

27. 27.

    Holzer G Hoke M Sabeti-Sandor S Perkmann T Rauscher A Strassegger B. Disparate Effects of Adalimumab and Fumaric Acid Esters on Cardiovascular Risk Factors in Psoriasis Patients: Results From a Prospective, Randomized, Observer-Blinded Head-To-Head Trial. J Eur Acad Dermatol Venereol (2021 ) 35(2):441–9

    Not in our library10.1111/jdv.16635

28. 28.

    Hong JR Jeong H Kim H Yang HS Hong JY Kim SM. The Potential Impact of Systemic Anti-Inflammatory Therapies in Psoriasis on Major Adverse Cardiovascular Events: A Korean Nationwide Cohort Study. Sci Rep (2021 ) 11(1):8588

    Not in our library10.1038/s41598-021-87766-y

29. 29.

    Aune D Snekvik I Schlesinger S Norat T Riboli E Vatten LJ. Body Mass Index, Abdominal Fatness, Weight Gain and the Risk of Psoriasis: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies. Eur J Epidemiol Q1 (2018 ) 33(12):1163–78

    Not in our library10.1007/s10654-018-0366-z

30. 30.

    Friis NU Hoffmann N Gyldenløve M Skov L Vilsbøll T Knop FK. Glucose Metabolism in Patients With Psoriasis. Br J Dermatol (2019 ) 180(2):264–71

    Not in our library10.1111/bjd.17349

31. 31.

    Rodríguez-Zúñiga MJM García-Perdomo HA. Systematic Review and Meta-Analysis of the Association Between Psoriasis and Metabolic Syndrome. J Am Acad Dermatol (2017 ) 77(4):657–66.e8

    Not in our library10.1016/j.jaad.2017.04.1133

32. 32.

    Pietrzak A Grywalska E Walankiewicz M Lotti T Roliński J Myśliński W. Psoriasis and Metabolic Syndrome in Children: Current Data. Clin Exp Dermatol (2017 ) 42(2):131–6

    Not in our library10.1111/ced.13014

33. 33.

    Wu MY Yu CL Yang SJ Chi CC. Change in Body Weight and Body Mass Index in Psoriasis Patients Receiving Biologics: A Systematic Review and Network Meta-Analysis. J Am Acad Dermatol (2020 ) 82(1):101–9

    Not in our library10.1016/j.jaad.2019.07.103

34. 34.

    Zou Q Si J Guo Y Yu J Shi H. Association Between Serum Visfatin Levels and Psoriasis and Their Correlation With Disease Severity: A Meta-Analysis. J Int Med Res (2021 ) 49(3):3000605211002381

    Not in our library10.1177/03000605211002381

35. 35.

    Kim ES Han K Kim MK Park YM Baek KH Moon SD. Impact of Metabolic Status on the Incidence of Psoriasis: A Korean Nationwide Cohort Study. Sci Rep (2017 ) 7(1):1989

    Not in our library10.1038/s41598-017-01983-y

36. 36.

    Han JH Lee JH Han KD Kim HN Bang CH Park YM. Increased Risk of Psoriasis in Subjects With Abdominal Obesity: A Nationwide Population-Based Study. J Dermatol (2019 ) 46(8):695–701

    Not in our library10.1111/1346-8138.14939

37. 37.

    Ferguson LD Brown R Celis-Morales C Welsh P Lyall DM Pell JP. Association of Central Adiposity With Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis: A Cross-Sectional Study of the Uk Biobank. Rheumatology (Oxford) (2019 ) 58(12):2137–42

    Not in our library10.1093/rheumatology/kez192

38. 38.

    Ogawa K Stuart PE Tsoi LC Suzuki K Nair RP Mochizuki H. A Transethnic Mendelian Randomization Study Identifies Causality of Obesity on Risk of Psoriasis. J Invest Dermatol (2019 ) 139(6):1397–400

    Not in our library10.1016/j.jid.2018.11.023

39. 39.
    Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study · 2019

    No notice
40. 40.

    Gui XY Yu XL Jin HZ Zuo YG Wu C. Prevalence of Metabolic Syndrome in Chinese Psoriasis Patients: A Hospital-Based Cross-Sectional Study. J Diabetes Investig (2018 ) 9(1):39–43

    Not in our library10.1111/jdi.12663

Cited by papers we hold 1

• Development and Validation of the Cell-based Functional Method for Neutralizing Anti-adalimumab Antibodies Detection in Human Serum · 2024
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.